Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1994 | 1 |
2019 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Quoted phrase not found in phrase index: "Refractory Thyroid Gland Medullary Carcinoma"
Page 1
Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfalls.
BMC Cancer. 2019 Apr 5;19(1):325. doi: 10.1186/s12885-019-5540-5.
BMC Cancer. 2019.
PMID: 30953466
Free PMC article.
BACKGROUND: For progressive metastatic medullary thyroid carcinoma (MTC), the available treatment options with tyrosine kinase inhibitors result in grade 3-4 adverse events in a large number of patients. ...METHODS: Retrospective evaluation of treatment effec …
BACKGROUND: For progressive metastatic medullary thyroid carcinoma (MTC), the available treatment options with tyrosine …
Chronic refractory diarrhoea: a manifestation of endocrine disorders.
Alam MJ.
Alam MJ.
Dig Dis. 1994 Jan-Feb;12(1):46-61. doi: 10.1159/000171436.
Dig Dis. 1994.
PMID: 8200124
Review.
Hormonally mediated chronic refractory diarrhoeas constitute a rare but important group which often defy precise diagnosis when conventional routine diagnostic methods are used. Hormonal diarrhoea may occur in carcinoid syndrome, medullary carcinoma of the …
Hormonally mediated chronic refractory diarrhoeas constitute a rare but important group which often defy precise diagnosis when conve …
Item in Clipboard
Cite
Cite